Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(1.29)
# 3,426
Out of 4,761 analysts
276
Total ratings
33.99%
Success rate
-13.78%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABEO Abeona Therapeutics | Reiterates: Buy | $15 | $5.78 | +159.52% | 1 | Feb 19, 2025 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $70 → $72 | $57.75 | +24.68% | 33 | Feb 19, 2025 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $65 | $47.91 | +35.67% | 2 | Feb 13, 2025 | |
| SRPT Sarepta Therapeutics | Reiterates: Sell | $75 | $106.28 | -29.43% | 5 | Feb 13, 2025 | |
| RLYB Rallybio | Reiterates: Buy | $5 | $0.75 | +563.13% | 18 | Feb 12, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $45 | $11.02 | +308.35% | 5 | Feb 7, 2025 | |
| ALMS Alumis | Maintains: Buy | $26 → $19 | $5.17 | +267.50% | 5 | Feb 7, 2025 | |
| RNAC Cartesian Therapeutics | Reiterates: Buy | $45 | $19.24 | +133.89% | 15 | Jan 28, 2025 | |
| LEGN Legend Biotech | Reiterates: Buy | $73 | $39.70 | +83.88% | 34 | Jan 23, 2025 | |
| IPSC Century Therapeutics | Reiterates: Buy | $5 | $0.73 | +584.84% | 15 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $44 | $22.12 | +98.92% | 12 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $13.17 | +127.79% | 17 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.78 | - | 7 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $5 | $1.40 | +257.14% | 5 | Dec 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.45 | - | 12 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $14 | $2.36 | +493.22% | 8 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5.6 → $2.4 | $2.50 | -4.00% | 3 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $17.36 | +216.82% | 13 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $115 | $26.29 | +337.43% | 10 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $2.78 | +115.83% | 5 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.66 | +442.17% | 14 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $22.12 | +397.29% | 13 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $23 | $3.89 | +491.26% | 5 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $1 | $0.70 | +42.71% | 10 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $7.28 | +92.31% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $2,440 | $0.09 | +2,666,566.67% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.64 | - | 4 | Jun 2, 2023 |
Abeona Therapeutics
Feb 19, 2025
Reiterates: Buy
Price Target: $15
Current: $5.78
Upside: +159.52%
Halozyme Therapeutics
Feb 19, 2025
Maintains: Buy
Price Target: $70 → $72
Current: $57.75
Upside: +24.68%
CRISPR Therapeutics AG
Feb 13, 2025
Reiterates: Buy
Price Target: $65
Current: $47.91
Upside: +35.67%
Sarepta Therapeutics
Feb 13, 2025
Reiterates: Sell
Price Target: $75
Current: $106.28
Upside: -29.43%
Rallybio
Feb 12, 2025
Reiterates: Buy
Price Target: $5
Current: $0.75
Upside: +563.13%
Oruka Therapeutics
Feb 7, 2025
Reiterates: Buy
Price Target: $45
Current: $11.02
Upside: +308.35%
Alumis
Feb 7, 2025
Maintains: Buy
Price Target: $26 → $19
Current: $5.17
Upside: +267.50%
Cartesian Therapeutics
Jan 28, 2025
Reiterates: Buy
Price Target: $45
Current: $19.24
Upside: +133.89%
Legend Biotech
Jan 23, 2025
Reiterates: Buy
Price Target: $73
Current: $39.70
Upside: +83.88%
Century Therapeutics
Jan 22, 2025
Reiterates: Buy
Price Target: $5
Current: $0.73
Upside: +584.84%
Jan 21, 2025
Reiterates: Buy
Price Target: $44
Current: $22.12
Upside: +98.92%
Jan 13, 2025
Reiterates: Buy
Price Target: $30
Current: $13.17
Upside: +127.79%
Jan 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.78
Upside: -
Dec 24, 2024
Reiterates: Neutral
Price Target: $5
Current: $1.40
Upside: +257.14%
Dec 16, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.45
Upside: -
Dec 10, 2024
Maintains: Buy
Price Target: $7 → $14
Current: $2.36
Upside: +493.22%
Dec 6, 2024
Maintains: Buy
Price Target: $5.6 → $2.4
Current: $2.50
Upside: -4.00%
Nov 25, 2024
Reiterates: Buy
Price Target: $55
Current: $17.36
Upside: +216.82%
Nov 22, 2024
Reiterates: Buy
Price Target: $115
Current: $26.29
Upside: +337.43%
Nov 20, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $2.78
Upside: +115.83%
Nov 19, 2024
Reiterates: Buy
Price Target: $9
Current: $1.66
Upside: +442.17%
Nov 18, 2024
Reiterates: Buy
Price Target: $110
Current: $22.12
Upside: +397.29%
Nov 14, 2024
Maintains: Buy
Price Target: $21 → $23
Current: $3.89
Upside: +491.26%
Nov 12, 2024
Reiterates: Neutral
Price Target: $1
Current: $0.70
Upside: +42.71%
Nov 6, 2024
Maintains: Buy
Price Target: $15 → $14
Current: $7.28
Upside: +92.31%
Sep 6, 2023
Maintains: Buy
Price Target: $160 → $2,440
Current: $0.09
Upside: +2,666,566.67%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $2.64
Upside: -